Arcadia Biosciences (RKDA) Reports Q2 Loss of $2.02

Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($2.02), versus ($1.88) reported last year. Revenue for the quarter came in at $436 thousand versus the consensus estimate of $991 thousand.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
• Universal Health Realty (UHT) Reports Q1 EPS of $0.38
• Towne Bank (TOWN) Reports In-Line Q1 EPS